INNOVENT
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

INNOVENT Trademark

Serial Number: 79234854 • Registration: 6015574

INNOVENT is a trademark filed by Innovent Biologics (Suzhou) Co., Ltd. on April 16, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Innovent Biologics (Suzhou) Co., Ltd. (14 trademarks)

No. 168, Dongping Street
Suzhou City, Jiangsu Province , CN

Entity Type: 99

Trademark Details

Filing Date

April 16, 2018

Registration Date

March 24, 2020

Published for Opposition

January 7, 2020

Goods & Services

Medicines for human purposes, namely, antibody preparations, protein preparations, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Pharmaceutical preparations, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Vaccines; drugs for medical purposes, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Biological preparations for medical purposes, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Diagnostic preparations for medical purposes; Biological tissue cultures for medical purposes; Chemical reagents for medical purposes; all of the aforesaid excluding goods in gaseous form, goods related to nitric oxide, and veterinary products, preparations, reagents, and medicine for animal health

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 24, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 31, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 10, 2020 FICS
FINAL DISPOSITION PROCESSED
Jul 10, 2020 FIMP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 25, 2020 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 25, 2020 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 24, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jan 3, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2019 NONP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 13, 2019 OPNX
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 4, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 4, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 4, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 4, 2019 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 27, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 27, 2019 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 18, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 18, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 18, 2019 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 29, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 29, 2019 REAP
NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Oct 28, 2019 GAUN
NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Oct 28, 2019 GAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Oct 28, 2019 NAUD
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 25, 2019 ERFR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 25, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 25, 2019 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 13, 2019 GNFN
FINAL REFUSAL E-MAILED
Aug 13, 2019 GNFR
FINAL REFUSAL WRITTEN
Aug 13, 2019 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 16, 2019 RCCK
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jan 18, 2019 LIME
DATA MODIFICATION COMPLETED
Dec 12, 2018 DMCC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 11, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 11, 2018 GNSL
SUSPENSION LETTER WRITTEN
Dec 11, 2018 CNSL
LIMITATION OF GOODS RECEIVED FROM IB
Dec 7, 2018 LIMG
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 26, 2018 CHAN
DATA MODIFICATION COMPLETED
Nov 26, 2018 DMCC
ASSIGNED TO LIE
Nov 21, 2018 ALIE
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 19, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 19, 2018 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 19, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 19, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 19, 2018 TROA
REFUSAL PROCESSED BY IB
Sep 7, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 20, 2018 RFCS
REFUSAL PROCESSED BY MPU
Aug 20, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 4, 2018 RFCR
NON-FINAL ACTION WRITTEN
Aug 3, 2018 CNRT
ASSIGNED TO EXAMINER
Aug 3, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 6, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 25, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 21, 2018 REPR